Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
January 1, 2005International Heart JournalOpen Access

Surgical treatment of left-sided prosthetic valve thrombosis resulted in a 20% early hospital mortality rate, with no deaths or recurrences observed during a median follow-up of 29.2 months among survivors.

View Full Paper
Ask AI
Bookmark
Share

Population

30 patients with left-sided prosthetic valve thrombosis (PVT)

Design

Case_series

Follow-up

median 29.2 months (range 3 to 73 months)

Key result

Surgical treatment of left-sided prosthetic valve thrombosis resulted in a 20% early hospital mortality rate, with no deaths or recurrences observed during a median follow-up of 29.2 months among survivors.

Authors

MÖMehmet ÖzkökeliYŞYavuz ŞensözMAMehmet Ateş

Discussion

Loading...

Member takes

Overview

High early mortality in NYHA IV warrants caution for surgery; hypothesis-generating for long-term outcomes in milder cases.

Study Design

Type

Observational (n=30)

Multicenter

No

Structured PICO

P
Population
30 patients (mean age 41, 60% female) with left-sided prosthetic valve thrombosis who underwent surgical treatment, followed for a median of 29.2 months.
I
Intervention
Surgical treatment
O
Outcome
Early hospital mortality, long-term mortality, and recurrence of thrombosishard clinical

Surgical treatment of left-sided prosthetic valve thrombosis yields excellent long-term outcomes, though early mortality is significantly higher in patients presenting with NYHA class IV symptoms.

Limitations

  • Single center experience
  • Small sample size
  • Retrospective design
  • Relatively short follow-up period
  • Unsuccessful telephone follow-up for 6 patients

Cite This Study

Özkökeli et al. (2005) conducted an observational in Left-sided prosthetic valve thrombosis (n=30). Surgical treatment (valve replacement or thrombectomy) was evaluated on Early hospital mortality. Surgical treatment of left-sided prosthetic valve thrombosis resulted in a 20% early hospital mortality rate, with no deaths or recurrences observed during a median follow-up of 29.2 months among survivors.

synapsesocial.com/papers/6a503a71a1cf396479ce9ef9https://doi.org/10.1536/ihj.46.105
View Full Paper
Ask AI
Bookmark
Share